SERVICE & SUPPORT

Schedule a Demo

What are the inclusion criteria for treatment?

Share Article:

February 23, 2022

Patients with documented vascular related ED and no hormonal, neurologic or psychological pathology

Share:

More ARTICLES

Shockwave Lithotripsy Technology in times of laser

October 30, 2023

Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients

September 28, 2023

Long-term effects of combination treatment comprising low-intensity extracorporeal shockwave therapy and tadalafil for patients with erectile dysfunction: a retrospective study

September 28, 2023

MEDICA 2023

September 18, 2023

Related Posts

Shockwave Lithotripsy Technology in times of laser

Hear guest speaker Dr. John J. Pahira, M.D, at the webinar, Shockwave Lithotripsy Technology in times of laser” Nov. 27, 2023

Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients

Long-term effects of combination treatment comprising low-intensity extracorporeal shockwave therapy and tadalafil for patients with erectile dysfunction: a retrospective study

MEDICA 2023

International Trade Fair with conferences and forums for Medical Technology, Electromedicine, Health-IT, Laboratory Equipment, Diagnostics and Drugs.